Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

iRhythm Holdings (IRTC) R&D In Process (2024 - 2026)

iRhythm Holdings has reported R&D In Process over the past 3 years, most recently at $296000.0 for Q1 2026.

  • Quarterly R&D In Process changed 0.0% to $296000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Mar 2026, down 90.71% year-over-year, with the annual reading at $3.0 million for FY2025, 90.63% down from the prior year.
  • R&D In Process was $296000.0 for Q1 2026 at iRhythm Holdings, down from $740000.0 in the prior quarter.
  • Over five years, R&D In Process peaked at $32.1 million in Q3 2024 and troughed at $296000.0 in Q1 2025.
  • The 3-year median for R&D In Process is $331000.0 (2024), against an average of $5.1 million.
  • The largest YoY upside for R&D In Process was 123.56% in 2025 against a maximum downside of 99.06% in 2025.
  • A 3-year view of R&D In Process shows it stood at $331000.0 in 2024, then soared by 123.56% to $740000.0 in 2025, then plummeted by 60.0% to $296000.0 in 2026.
  • Per Business Quant, the three most recent readings for IRTC's R&D In Process are $296000.0 (Q1 2026), $740000.0 (Q4 2025), and $302000.0 (Q3 2025).